Global Veterinary Medicine Market Research Report—Forecast till 2027

  • Licence Type:
  • Single User - $4450
  • Multi User - $6250
  • Enterprise User - $6250

Market Synopsis Global Veterinary Medicine Market is anticipated to witness a healthy CAGR of 5.57% during the review period of 2020 to 2027. The rising rates of pet ownership, increasing chronic diseases, and growing consumption of meat are expected to create many growth opportunities for the global market. Apart from meat utilization, the dairy items request has likewise flooded. Expanding meat and dairy utilization request the security of domesticated animals and consistent checking of their wellbeing to capture the spread of illnesses from creatures to people. Amid the developing meat utilization, the emphasis on improving the wellbeing of new meat has expanded. The global veterinary medicine market is expected to register a significant market owing to the largest value at USD 28,012.73 Million in 2019. The increasing predominance of diseases in animals poses a serious threat to food security. Climate change and globalization are the major reasons attributing to the rise in diseases among animals. Moreover, the increase in the number of pet ownerships is propelling the requirement for better care of companion animals, driving the overall expenditure on pets. Market Segmentation Global Veterinary Medicine Market has been classified into Animal Type, Product, Route of Administration, and Distribution Channel. In terms of animal type, the global market has been divided into domesticated and companion. In terms of product segments, the market is segmented into drugs and vaccines. By the route of administration, the market is categorized into oral, parental, and others. Based on the distribution channel, the market is divided into veterinary hospitals & clinics, retail stores, and online pharmacies. Regional Analysis Geographically, the Global Veterinary Medicine Market has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa. The Americas is likely to contribute the largest market owing to the increase in companion animal ownership and the rising prevalence of animal diseases in the region. As per Atlas Dental, a total of 69,075 dental operations were performed in German hospitals in 2017. Additionally, the global market growth is attributed to the increasing population of pets and livestock with a high number of veterinary practices. Europe contributes to the second-largest market in the global veterinary medicine market during the review period. The regional market is driven by the increasing prevalence of diseases, new product approvals, and the existence of developed veterinary healthcare infrastructure. Asia-Pacific is expected to attain the fastest-growing market during the review period. The regional market is driven by the increasing penetration of the veterinary sector, the increase in the number of private veterinary clinics, growing awareness about animal welfare, and government campaigns for the welfare of pet animals in China, Japan, India, South Korea, and Australia. The veterinary medicine market in Middle East & Africa is anticipated to register steady growth during the forecast period owing to the presence of developing countries in the region. Major Players The Key Players in the Global Veterinary Medicine Market are Boehringer Ingelheim, Ceva, Chanelle Pharma Group, Dechra Pharmaceuticals plc, Elanco, Merck Animal Health, Norbrook Laboratories, Vetoquinol S.A., Bayer AG, and Zoetis. COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 15 2.2 RESEARCH OBJECTIVE 15 2.3 MARKET STRUCTURE 15 2.4 ASSUMPTIONS & LIMITATIONS 16 3 RESEARCH METHODOLOGY 3.1 DATA MINING 17 3.2 SECONDARY RESEARCH 18 3.3 PRIMARY RESEARCH 19 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20 3.5 FORECASTING TECHNIQUES 20 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22 3.6.1 BOTTOM-UP APPROACH 23 3.6.2 TOP-DOWN APPROACH 23 3.7 DATA TRIANGULATION 24 3.8 VALIDATION 24 4 MARKET DYNAMICS 4.1 OVERVIEW 25 4.2 DRIVERS 26 4.2.1 GROWING RATES OF PET OWNERSHIP 26 4.2.2 RISING ZOONOTIC & CHRONIC DISEASES ANIMALS 26 4.2.3 INCREASING MEAT CONSUMPTION ATTRACTING MANDATORY VACCINATION 26 4.3 RESTRAINT 27 4.3.1 SHORTAGE OF VETERINARIANS 27 4.3.2 STRINGENT REGULATORY GUIDELINES PERTAINING TO VACCINES APPROVAL FOR ANIMALS 27 4.4 OPPORTUNITY 28 4.4.1 INCREASING INVESTMENT IN VETERINARY HOSPITALS 28 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 29 5.1.1 R&D 30 5.1.2 MANUFACTURING 30 5.1.3 DISTRIBUTION & SALES 30 5.1.4 POST-SALES REVIEW/MONITORING 30 5.2 PORTER'S FIVE FORCES MODEL 31 5.2.1 THREAT OF NEW ENTRANTS 31 5.2.2 BARGAINING POWER OF SUPPLIERS 32 5.2.3 THREAT OF SUBSTITUTES 32 5.2.4 BARGAINING POWER OF BUYERS 32 5.2.5 INTENSITY OF RIVALRY 32 5.3 IMPACT OF COVID-19 32 5.3.1 OVERVIEW 32 5.3.2 IMPACT ON MEAT CONSUMPTION 33 5.3.3 IMPACT ON VETERINARY MEDICINE MARKET 33 6 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE 6.1 OVERVIEW 34 6.2 DOMESTICATED 35 6.3 COMPANION 35 7 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT 7.1 OVERVIEW 37 7.2 DRUG 38 7.3 VACCINES 39 8 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION 8.1 OVERVIEW 40 8.2 ORAL 41 8.3 PARENTERAL 41 8.4 OTHERS 42 9 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL 9.1 OVERVIEW 43 9.2 VETERINARY HOSPITALS & CLINICS 44 9.3 RETAIL STORES 44 9.4 ONLINE PHARMACIES 45 10 GLOBAL VETERINARY MEDICINE MARKET, BY REGION 10.1 OVERVIEW 46 10.2 AMERICAS 48 10.2.1 NORTH AMERICA 50 10.2.1.1 US 52 10.2.1.2 CANADA 53 10.2.2 LATIN AMERICA 54 10.3 EUROPE 56 10.3.1 WESTERN EUROPE 58 10.3.1.1 GERMANY 60 10.3.1.2 UK 61 10.3.1.3 FRANCE 62 10.3.1.4 ITALY 63 10.3.1.5 SPAIN 64 10.3.1.6 REST OF WESTERN EUROPE 65 10.3.2 EASTERN EUROPE 67 10.4 ASIA-PACIFIC 69 10.4.1 CHINA 71 10.4.2 JAPAN 72 10.4.3 INDIA 73 10.4.4 AUSTRALIA 74 10.4.5 SOUTH KOREA 75 10.4.6 REST OF ASIA-PACIFIC 76 10.5 MIDDLE EAST & AFRICA 78 10.5.1 SAUDI ARABIA 80 10.5.2 UNITED ARAB EMIRATES 81 10.5.3 OMAN 83 10.5.4 KUWAIT 84 10.5.5 QATAR 85 10.5.6 REST OF THE MIDDLE EAST & AFRICA 86 11 COMPETITIVE LANDSCAPE 11.1 OVERVIEW 88 11.2 COMPETITIVE BENCHMARKING 89 11.3 GLOBAL VETERINARY MEDICINE MARKET: COMPANY RANKING 90 11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 91 11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY MEDICINE MARKET 91 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 92 11.6.1 NEW PRODUCT LAUNCHES 92 11.6.2 PARTNERSHIPS/AGREEMENTS 92 11.6.3 EXPANSIONS 93 11.6.4 ACQUISITIONS 93 11.7 FINANCIAL MATRIX 94 12 COMPANY PROFILES 12.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 96 12.1.1 COMPANY OVERVIEW 96 12.1.2 FINANCIAL OVERVIEW 97 12.1.3 PRODUCTS/SERVICES OFFERED 97 12.1.4 KEY DEVELOPMENTS 99 12.1.5 SWOT ANALYSIS 99 12.1.6 KEY STRATEGIES 100 12.2 CEVA 101 12.2.1 COMPANY OVERVIEW 101 12.2.2 FINANCIAL OVERVIEW 101 12.2.3 PRODUCTS/SERVICES OFFERED 102 12.2.4 KEY DEVELOPMENTS 102 12.2.5 SWOT ANALYSIS 103 12.2.6 KEY STRATEGIES 103 12.3 ZOETIS 104 12.3.1 COMPANY OVERVIEW 104 12.3.2 FINANCIAL OVERVIEW 104 12.3.3 PRODUCTS/SERVICES OFFERED 105 12.3.4 KEY DEVELOPMENTS 107 12.3.5 SWOT ANALYSIS 107 12.3.6 KEY STRATEGIES 107 12.4 MERCK ANIMAL HEALTH 108 12.4.1 COMPANY OVERVIEW 108 12.4.2 FINANCIAL OVERVIEW 109 12.4.3 PRODUCTS/SERVICES OFFERED 110 12.4.4 KEY DEVELOPMENTS 111 12.4.5 SWOT ANALYSIS 112 12.4.6 KEY STRATEGIES 112 12.5 CHANELLE PHARMA GROUP 113 12.5.1 COMPANY OVERVIEW 113 12.5.2 FINANCIAL OVERVIEW 113 12.5.3 PRODUCTS/SERVICES OFFERED 113 12.5.4 KEY DEVELOPMENTS 115 12.5.5 SWOT ANALYSIS 115 12.5.6 KEY STRATEGIES 115 12.6 ELANCO 116 12.6.1 COMPANY OVERVIEW 116 12.6.2 FINANCIAL OVERVIEW 117 12.6.3 PRODUCTS/SERVICES OFFERED 118 12.6.4 KEY DEVELOPMENTS 119 12.6.5 SWOT ANALYSIS 120 12.6.6 KEY STRATEGIES 120 12.7 DECHRA PHARMACEUTICALS PLC 121 12.7.1 COMPANY OVERVIEW 121 12.7.2 FINANCIAL OVERVIEW 121 12.7.3 PRODUCTS/SERVICES OFFERED 122 12.7.4 KEY DEVELOPMENTS 123 12.7.5 SWOT ANALYSIS 123 12.7.6 KEY STRATEGIES 123 12.8 BAYER AG 124 12.8.1 COMPANY OVERVIEW 124 12.8.2 FINANCIAL OVERVIEW 124 12.8.3 PRODUCTS/SERVICES OFFERED 125 12.8.4 KEY DEVELOPMENTS 126 12.8.5 SWOT ANALYSIS 127 12.8.6 KEY STRATEGIES 127 12.9 VETOQUINOL SA. 128 12.9.1 COMPANY OVERVIEW 128 12.9.2 FINANCIAL OVERVIEW 128 12.9.3 PRODUCTS/SERVICES OFFERED 129 12.9.4 KEY DEVELOPMENTS 131 12.9.5 SWOT ANALYSIS 132 12.9.6 KEY STRATEGIES 132 12.10 NORBROOK LABORATORIES 133 12.10.1 COMPANY OVERVIEW 133 12.10.2 FINANCIAL OVERVIEW 133 12.10.3 PRODUCTS/SERVICES OFFERED 133 12.10.4 KEY DEVELOPMENTS 135 12.10.5 SWOT ANALYSIS 135 12.10.6 KEY STRATEGIES 136 13 APPENDIX 13.1 REFERENCES 137 13.2 RELATED REPORTS 138

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 16 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19 TABLE 3 GLOBAL VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 34 TABLE 4 GLOBAL VETERINARY MEDICINE MARKET FOR DOMESTICATED, BY REGION, 2017–2027 (USD MILLION) 35 TABLE 5 GLOBAL VETERINARY MEDICINE MARKET FOR COMPANION, BY REGION, 2017–2027 (USD MILLION) 36 TABLE 6 GLOBAL VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 37 TABLE 7 GLOBAL VETERINARY MEDICINE MARKET FOR DRUG, BY REGION, 2017–2027 (USD MILLION) 38 TABLE 8 GLOBAL VETERINARY MEDICINE MARKET FOR VACCINES, BY REGION, 2017–2027 (USD MILLION) 39 TABLE 9 GLOBAL VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 40 TABLE 10 GLOBAL VETERINARY MEDICINE MARKET FOR ORAL, BY REGION, 2017–2027 (USD MILLION) 41 TABLE 11 GLOBAL VETERINARY MEDICINE MARKET FOR PARENTERAL, BY REGION, 2017–2027 (USD MILLION) 41 TABLE 12 GLOBAL VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 43 TABLE 13 GLOBAL VETERINARY MEDICINE MARKET FOR VETERINARY HOSPITALS & CLINICS, BY REGION, 2017–2027 (USD MILLION) 44 TABLE 14 GLOBAL VETERINARY MEDICINE MARKET FOR RETAIL STORES, BY REGION, 2017–2027 (USD MILLION) 45 TABLE 15 GLOBAL VETERINARY MEDICINE MARKET FOR ONLINE PHARMACIES, BY REGION, 2017–2027 (USD MILLION) 45 TABLE 16 GLOBAL VETERINARY MEDICINE MARKET, BY REGION, 2017–2027 (USD MILLION) 46 TABLE 17 AMERICAS: VETERINARY MEDICINE MARKET, BY REGION, 2017–2027 (USD MILLION) 48 TABLE 18 AMERICAS: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 49 TABLE 19 AMERICAS: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 49 TABLE 20 AMERICAS: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 49 TABLE 21 AMERICAS: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 49 TABLE 22 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 50 TABLE 23 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 50 TABLE 24 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 51 TABLE 25 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 51 TABLE 26 NORTH AMERICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 51 TABLE 27 US: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 52 TABLE 28 US: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 52 TABLE 29 US: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 52 TABLE 30 US: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 52 TABLE 31 CANADA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 53 TABLE 32 CANADA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 53 TABLE 33 CANADA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 53 TABLE 34 CANADA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 53 TABLE 35 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 54 TABLE 36 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 54 TABLE 37 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 54 TABLE 38 LATIN AMERICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 55 TABLE 39 EUROPE: VETERINARY MEDICINE MARKET, BY REGION, 2017–2027 (USD MILLION) 56 TABLE 40 EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 57 TABLE 41 EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 57 TABLE 42 EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 57 TABLE 43 EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 57 TABLE 44 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 58 TABLE 45 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 58 TABLE 46 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 59 TABLE 47 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 59 TABLE 48 WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 59 TABLE 49 GERMANY: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 60 TABLE 50 GERMANY: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 60 TABLE 51 GERMANY: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 60 TABLE 52 GERMANY: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 61 TABLE 53 UK: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 61 TABLE 54 UK: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 61 TABLE 55 UK: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 61 TABLE 56 UK: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 62 TABLE 57 FRANCE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 62 TABLE 58 FRANCE: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 62 TABLE 59 FRANCE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 62 TABLE 60 FRANCE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 63 TABLE 61 ITALY: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 63 TABLE 62 ITALY: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 63 TABLE 63 ITALY: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 63 TABLE 64 ITALY: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 64 TABLE 65 SPAIN: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 64 TABLE 66 SPAIN: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 64 TABLE 67 SPAIN: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 65 TABLE 68 SPAIN: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 65 TABLE 69 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 65 TABLE 70 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 66 TABLE 71 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 66 TABLE 72 REST OF WESTERN EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 66 TABLE 73 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 67 TABLE 74 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 67 TABLE 75 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 67 TABLE 76 EASTERN EUROPE: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 68 TABLE 77 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY COUNTRY, 2017–2027 (USD MILLION) 69 TABLE 78 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 70 TABLE 79 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 70 TABLE 80 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 70 TABLE 81 ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 70 TABLE 82 CHINA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 71 TABLE 83 CHINA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 71 TABLE 84 CHINA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 71 TABLE 85 CHINA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 71 TABLE 86 JAPAN: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 72 TABLE 87 JAPAN: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 72 TABLE 88 JAPAN: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 72 TABLE 89 JAPAN: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 72 TABLE 90 INDIA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 73 TABLE 91 INDIA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 73 TABLE 92 INDIA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 73 TABLE 93 INDIA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 73 TABLE 94 AUSTRALIA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 74 TABLE 95 AUSTRALIA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 74 TABLE 96 AUSTRALIA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 74 TABLE 97 AUSTRALIA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 75 TABLE 98 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 75 TABLE 99 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 75 TABLE 100 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 76 TABLE 101 SOUTH KOREA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 76 TABLE 102 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 76 TABLE 103 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 77 TABLE 104 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 77 TABLE 105 REST OF ASIA-PACIFIC: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 77 TABLE 106 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY COUNTRY/REGION, 2017–2027 (USD MILLION) 78 TABLE 107 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 79 TABLE 108 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 79 TABLE 109 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 79 TABLE 110 MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 80 TABLE 111 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 80 TABLE 112 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 80 TABLE 113 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 81 TABLE 114 SAUDI ARABIA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 81 TABLE 115 UAE VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 81 TABLE 116 UAE VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 82 TABLE 117 UAE VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 82 TABLE 118 UAE VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 82 TABLE 119 OMAN: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 83 TABLE 120 OMAN: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 83 TABLE 121 OMAN: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 83 TABLE 122 OMAN: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 83 TABLE 123 KUWAIT: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 84 TABLE 124 KUWAIT: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 84 TABLE 125 KUWAIT: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 84 TABLE 126 KUWAIT: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 84 TABLE 127 QATAR: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 85 TABLE 128 QATAR: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 85 TABLE 129 QATAR: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 85 TABLE 130 QATAR: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 85 TABLE 131 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2017–2027 (USD MILLION) 86 TABLE 132 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY PRODUCT, 2017–2027 (USD MILLION) 86 TABLE 133 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2017–2027 (USD MILLION) 86 TABLE 134 REST OF THE MIDDLE EAST & AFRICA: VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2017–2027 (USD MILLION) 87 TABLE 135 MAJOR MANUFACTURERS RANKING, 2019 90 TABLE 136 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE VETERINARY MEDICINE MARKET 91 TABLE 137 NEW PRODUCT LAUNCHES 92 TABLE 138 PARTNERSHIPS/AGREEMENTS 92 TABLE 139 EXPANSIONS 93 TABLE 140 ACQUISITIONS 93 TABLE 141 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SERVICES OFFERED 97 TABLE 142 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS 99 TABLE 143 CEVA: PRODUCTS/SERVICES OFFERED 102 TABLE 144 CEVA: KEY DEVELOPMENTS 102 TABLE 145 ZOETIS: PRODUCTS/SERVICES OFFERED 105 TABLE 146 ZOETIS: KEY DEVELOPMENTS 107 TABLE 147 MERCK ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 110 TABLE 148 MERCK ANIMAL HEALTH: KEY DEVELOPMENTS 111 TABLE 149 CHANELLE PHARMA GROUP: PRODUCTS/SERVICES OFFERED 113 TABLE 150 CHANELLE PHARMA GROUP: KEY DEVELOPMENTS 115 TABLE 151 CHANELLE PHARMA GROUP: SWOT ANALYSIS 115 TABLE 152 ELANCO: PRODUCTS/SERVICES OFFERED 118 TABLE 153 ELANCO: KEY DEVELOPMENTS 119 TABLE 154 DECHRA PHARMACEUTICALS PLC: PRODUCTS/SERVICES OFFERED 122 TABLE 155 DECHRA PHARMACEUTICALS PLC: KEY DEVELOPMENTS 123 TABLE 156 BAYER AG: PRODUCTS/SERVICES OFFERED 125 TABLE 157 VETOQUINOL SA: PRODUCTS/SERVICES OFFERED 129 TABLE 158 VETOQUINOL SA: KEY DEVELOPMENTS 131 TABLE 159 NORBROOK LABORATORIES: PRODUCTS/SERVICES OFFERED 133 TABLE 160 NORBROOK LABORATORIES: KEY DEVELOPMENTS 135

Related Reports

Ticagrelor Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Ticagrelor market was valued at approximately USD 1761.4 million in 2022, and is expected to reach around USD 4019.37 Million by end of 2031, growing at a CAGR of 9.6% during the period 2023-2031, according to Regal Intelligence. What the Report Offer? ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 103
Single user Price: $2450
Sucralfate Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Sucralfate market was valued at approximately USD 253.11 million in 2022, and is expected to reach around USD 361.73 Million by end of 2031, growing at a CAGR of 4.05% during the period 2023-2031, according to Regal Intelligence. What the Report Offer? ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 116
Single user Price: $2450
PSP System Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global PSP System market was valued at approximately USD 226.54 million in 2022, and is expected to reach around USD 238.82 Million by end of 2031, growing at a CAGR of 0.59% during the period 2023-2031, according to Regal Intelligence. What the Report Offer? ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 117
Single user Price: $2450
Vitamin D3 Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Vitamin D3 market was valued at approximately USD 553.21 million in 2022, and is expected to reach around USD 1158.41 Million by end of 2031, growing at a CAGR of 8.56% during the period 2023-2031, according to Regal Intelligence. What the Report Offer ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 107
Single user Price: $2450
Gout Drugs Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Gout Drugs market was valued at approximately USD 3240.33 million in 2022, and is expected to reach around USD 11214.63 Million by end of 2031, growing at a CAGR of 14.79% during the period 2023-2031, according to Regal Intelligence. What the Report Of ... read more

Category: Pharmaceuticals and Healthcare
Published: Oct 2023
Pages: 119
Single user Price: $2450